Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

3.170 +0.200 (+6.73%)
Official Closing Price Updated: 4:15 PM EDT, May 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
News headline image
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
News headline image
Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
Via MarketBeat
Topics Artificial Intelligence
News headline image
3 Biotech Stocks Using AI to Change Healthcare Forever ↗
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past. 
Via InvestorPlace
News headline image
Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About ↗
Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. 
Via Benzinga
News headline image
Where Recursion Pharmaceuticals Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Shares of Recursion Pharmaceuticals Are Skyrocketing Wednesday ↗
The company just received a $50 million investment from Nvidia. 
Via The Motley Fool
News headline image
Why Recursion Pharmaceuticals Stock Is Skyrocketing This Week (Hint: Thanks, Nvidia) ↗
The small biotech is enjoying the rewards of being linked to one of the hottest AI giants around. 
Via The Motley Fool
News headline image
Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play? ↗
RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment. 
Via InvestorPlace
News headline image
Why Recursion Pharmaceuticals (RXRX) Stock Is Falling Thursday ↗
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares are trading lower on Thursday as traders appear to be taking profits. The stock rallied on Wednesday after the company announced a $50 m 
Via Benzinga
News headline image
Top Trending Stocks: Recursion Pharmaceuticals, Beyond Meat, Tesla, Disney, NIO in Focus ↗
 
Via Benzinga
News headline image
Nvidia Just Invested in This Pharmaceutical Company, Causing Its Stock Price to Skyrocket ↗
Nvidia's investment in Recursion caused its stock price to jump dramatically on Tuesday. 
Via The Motley Fool
News headline image
RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring ↗
Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock. 
Via InvestorPlace
News headline image
Gold Rises Over 1%; Recursion Pharmaceuticals Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.33% to 34,374.56 while the NASDAQ rose 1.21% to 13,926.89. The S&P 500,... 
Via Benzinga
News headline image
Recursion Pharmaceuticals (NASDAQ: RXRX) Forms Powerful Partnership with NVIDIA (NASDAQ: NVDA)
A $50 Million Investment to Boost AI Capabilities in Drug Discovery Recursion Pharmaceuticals (NASDAQ: RXRX), a trailblazer in TechBio that 
Via Spotlight Growth
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks Extend Rally On Cooler-Than-Expected CPI Reading ↗
The S&P 500 Index and Nasdaq Composite sport solid midday leads, as investors hope the data may push the Federal Reserve away from more interest rate hikes. 
Via Talk Markets
News headline image
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
News headline image
Why Recursion Pharmaceuticals Stock is Skyrocketing Today? ↗
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares are trading higher after the company announced a $50 million investment by NVIDIA Corporation (NASDAQ: NVDA), executed as a private  
Via Benzinga
News headline image
S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected ↗
U.S. stocks traded higher midway through trading, with the S&P 500 gaining 1% on Wednesday. The Dow traded up 0.84% to 34,550.13 while the NASDAQ rose 1.32% to 13,941.87. The S&P 500, also rose,... 
Via Benzinga
News headline image
Recursion Catapults 70% On Nvidia Investment For AI In Drug Development ↗
Nvidia is hoping to help this company accelerate its efforts in AI-related drug development. 
Via Investor's Business Daily
News headline image
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Nasdaq Rises Over 1%; US Inflation Rate Falls In June ↗
U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.78% to 34,527.32 while the NASDAQ rose 1.18%... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster 
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom ↗
AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider. 
Via InvestorPlace
News headline image
Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now ↗
With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend. 
Via InvestorPlace
News headline image
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
Recursion's small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial for cerebral cavernous malformation (CCM). CCM is a devastating... 
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.